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ABSTRACT. Antibodies are affinity proteins with a wide spectrum of applications in analytical 
and therapeutic biology. Proteins showing specific recognition for a chosen molecular target can 
be isolated and their encoding sequence identified in vitro from a large and diverse library by 
phage display selection. In this work, we show that this standard biochemical technique rapidly 
yields a collection of antibody protein binders for an inorganic target of major technological 
importance: crystalline metallic gold surfaces. 21 distinct anti-gold antibody proteins emerged 
from a large random library of antibodies and were sequenced. The systematic statistical analysis 
of all the protein sequences reveals a strong occurrence of arginine in anti-gold antibodies, which 
corroborates recent molecular dynamics predictions on the crucial role of arginine in protein/gold 
interactions. Once tethered to small gold nanoparticles using histidine tag chemistry, the selected 
antibodies could drive the self-assembly of the colloids onto the surface of single crystalline gold 
platelets as a first step towards programmable protein-driven construction of complex plasmonic 
architectures. Electrodynamic simulations based on the Green Dyadic Method suggest that the 
antibody-driven assembly demonstrated here could be exploited to significantly modify the 
plasmonic modal properties of the gold platelets. Our work shows that molecular biology tools 
can be used to design the interaction between fully folded proteins and inorganic surfaces with 
potential applications in the bottom-up construction of plasmonic hybrid nanomaterials. 
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Taking advantage of the interaction specificity and engineering versatility of biomolecules 
holds promises towards the design of hybrid self-assembled materials by combining bio-
molecules and non-biological solid state nano-objects 1. For instance DNA has been used to self-
assemble nano-particles into three-dimensional (3D) crystals2,3. Proteins and peptides represent 
an alternative strategy offering a much wider chemical (20 amino-acids vs 4 nucleotides) and 
structural (viral capsids, microtubules, S-layers, …) repertoire. However, this strategy requires a 
deeper understanding of interactions between proteins and non-biological solid surfaces, which 
remains essentially elusive. Combinatorial chemistry has already demonstrated its power in 
revealing property-driven best-suited molecules 4, materials 5 or biomolecules 6 with no a priori 
knowledge of interaction mechanisms between the constituents and the environment in which the 
selection pressure is applied. Biomolecular display techniques are among the most advanced 
tools to date developed for such directed evolution approaches in biochemistry. Interestingly, 
peptides that bind tightly and specifically to solid surfaces such as metals, semi-conductors, 
magnetic metal oxides, conductive polymers and carbon nanotubes have been identified by in 
vitro phage-display screening of libraries containing typically 109 distinct, linear 9-12 amino-
acid peptides 7-9. Thereby, a better description of interactions between these peptides and their 
inorganic target surfaces is emerging through combined AFM, NMR and peptide sequence 
analysis 10-13. Remarkable advances in the affinity chemistry of biomolecule for solid interfaces 
have led to the programmed self-assembly of new materials based on phage bearing these 
peptides and their inorganic targets 14,15. To overcome intrinsic limitations of peptides, in 
particular the lack of a well-defined 3D structure, antibodies have been proposed as stronger and 
more stable binders 16. Therapeutic or cell-biological applications of antibodies rely on libraries 
of 109 recombinant antibody clones, that mimic human antibody repertoires, and which are 
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typically screened by phage display for isolating the few antibody interactants binding to the 
chosen bio-molecular targets 6. Such libraries have also been screened against inorganic solid 
surfaces, such as metals (Au) 17 and semi-conductors (GaAs) 16. These screens yield highly 
specific, versatile antibody binders of these inorganic crystalline solid surfaces, thus confirming 
the validity of the antibody-based combinatorial approach. Anti-Au antibodies do not bind other 
tested bare metal surfaces (Pt, Pd, Ag), and can be engineered to functionalize gold surfaces 17. 
Anti-GaAs antibodies bind specifically to [111A] crystal facets and not to [100] facets 16. While 
these seminal works highlight the potential of antibody-based nanomaterials engineering, they 
remain isolated cases, which makes it difficult to infer a more generic rationale. 
 
In this work, a library of 3 x 108 distinct antibody clones was screened against bare gold 
surfaces of micron-sized particles and yielded a collection of more than 20 gold-binding 
antibodies. We shed a new light on the interactions between anti-Au antibodies and gold surfaces 
by comparing their sequences to those of antibodies isolated against a polymer target or to the 
sequence of antibodies randomly picked from the same initial library. Furthermore, we exploit 
the specific binding affinity of the selected anti-Au antibodies to decorate the bare gold surface 
of large crystalline gold nanoprisms with sub-5-nm Au nanoparticles tethered to the anti-Au 
antibodies. Atomic Force Microscope (AFM) and Transmission Electron Microscopy (TEM) 
imaging reveals the binding of the 5-nm Au nanoparticle across the entire prism edges and 
surface. We corroborate these findings by performing similar experiments with PVP-coated Au 
nanoprisms and a different anti-PVP antibody recently identified 18 that was conjugated to the 
small Au nanoparticles. The effective selective binding affinity of these antibodies even after 
grafting onto the nanoparticle surface is an important milestone towards protein-driven 
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programmable self-assembly of functional nanomaterials such as plasmonic nanocrystals 19. 
Green Dyadic simulations indeed show that the surface plasmon local density of states (SP-
LDOS) of the Au nanoprism resonators is significantly modified by the presence of assembled 
nanoparticles on the nanoprism surface. 
Results and Discussion 
The Tomlinson I+J scFv antibody library contains 3 × 108 distinct antibody clones that share the 
same antibody framework and differ at 18 randomized amino-acid positions in the CDR2 and 
CDR3 regions of the heavy and light antibody Fv chains (respectively VH and VL), responsible 
for specific interactions of antibodies with antigens (Figs. 1a,b). This widely distributed library 
has been extensively screened against bio-molecular targets for the past decade and yielded 
many antibodies. In two earlier studies, we have demonstrated that the interactions between 
antibodies and non-biological targets could also be analyzed and optimized by screening the 
Tomlinson I+J scFv library. Our general strategy has been applied to two distinct targets: (i) a 
single-stranded DNA 20,21 and (ii) poly-vinylpyrrolidone (PVP), a synthetic, neutral, water-
soluble homopolymer of industrial interest 18. In particular, a new amino-acid motif, that drives 
the specific recognition of PVP chains, has been isolated by antibody phage display selection 
followed by the statistical analysis of the amino-acid sequences of selected antibody clones and 
combined with biochemical characterization of antibody/target interactions. The PVP-binding 
motif comprises tyrosine, glycine, asparagine and aspartic acid residues and is located in the 
antigen-binding CDR3 region of the VH moiety 18. 
Building up on our approach to analyze and exploit antibody/gold interactions, we have screened 
the Tomlinson I+J library against bare gold surfaces of micrometer-sized particles (Fig. 1c). The 
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yield of phage recovery (output vs input phage particle numbers) is similar at the first two 
selection rounds (10-7) but increases 500-fold at the third round (5 × 10-5). This suggests that 
three selection rounds result in the significant enrichment of the phage library with specific anti-
Au antibodies. 94 antibody clones were randomly picked from the third selection round output 
population, arrayed in 96-well plates containing two negative control wells, and assayed by 
ELISA for binding to gold micron-sized particles. 45 antibody clones out of 94 tested (48%) did 
bind to gold particles. The antibody-Au binding specificity is confirmed by a series of negative 
control experiments. First, none of them bind to plain 96-well plate, therefore excluding plastic-
bound phage selection (Fig. 2a). Secondly, selected anti-Au antibodies do not bind to bare 
metallic Ag, Cu or semiconducting ZnS surfaces, which rules out non-specific interactions of 
anti-Au antibodies with other inorganic solid surfaces (Fig. 2b). Thirdly, antibodies isolated from 
the same library, therefore sharing the same framework, but selected against PVP 18 do not bind 
to gold particles (Fig. 2c). This observation precludes non-specific interactions of the common 
antibody framework of the Tomlinson I+J library with gold surfaces. These experiments 
therefore demonstrate the specific binding of anti-Au antibodies to bare gold surfaces through 
their CDR regions. In contrast to previous reports of an anti-Au antibody that suffered from poor 
solubility 17, the anti-Au antibodies presented here are fully soluble and efficiently secreted by E. 
coli into the culture medium, with expression yields in the range from 1 mg to 10 mg per liter of 
culture. 
In order to gain further insight on the molecular signature of Au binding affinity, 31 anti-Au 
antibody clones were sequenced leading to the identification of 21 distinct sequences, the most 
redundant clone being represented 8 times (See Supplementary Information). This large number 
of different antibodies showing gold affinity allows for a detailed statistical analysis of the 
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protein sequences. To this end, the 21 anti-Au antibody sequences were aligned and a sequence 
logo analysis of the random CDR positions was performed as shown in Figure 3. The occurrence 
frequency of each of the 20 amino-acids is calculated for each random position, which yields a 
probability ranking represented by the symbol size in the sequence logo. For comparison, this 
analysis is applied to a set of 32 antibodies randomly picked from the initial library and to a set 
of 31 antibody selected from the same library against PVP 18. The strong selection for arginine 
(Arg) residues in anti-Au antibodies is clearly visible at most of the random positions of CDR2 
and CDR3 regions of VH and VL. In contrast, Arg residues are either totally absent or, at most, 
present at up to one position in the initial population or in anti-PVP antibody clones. 
Noteworthy, amino-acids at random positions of the Tomlinson J library are NNK-encoded 22, 
which results in a bias for Arg residues (9%) with respect to most other amino-acids (3% for 
tyrosine, for example) 23. This bias was, in part, compensated by using the I+J library that 
contains equal proportions of J library NNK-encoded clones and of I library DST-encoded 
clones, for which arginine residues are absent at random positions. Indeed, the maximum 1 Arg 
residue per antibody with 18 random positions found in the 32 random, non-selected clones from 
the initial I+J library corresponds to less than 6%. In contrast, in 21 anti-Au antibodies, 2 to 9 
Arg residues are observed, which amounts to an average of 4.3 ± 2 Arg per antibody, that is 
24 ± 11% of the random positions. This large occurrence of Arg residues reveals a statistically 
significant selection bias during the phage display rounds (Student’s t test, p=2.6 × 10-6). 
The involvement of Arginine in the Au surface binding is further confirmed by its spatial 
occurrence. Indeed, Arg is present in all CDR domains, which are the antigen-binding loops of 
antibodies. It is the 1st or 2nd top-ranked amino-acid at all 4 random positions of VH-CDR3, 
which is considered as the most important CDR region for antigen binding. It holds the same 
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predominance at 3 of the 7 random positions in the VH-CDR2 domain, at 1 of the 2 random 
positions of VL-CDR2 (3rd at the other position) and at 4 out of 5 random positions of VL-CDR3. 
In this context, the only occurrence of Arg in the non-selected sequence logo is only ranked 4th at 
a single random position. Similarly, Arg is totally absent from all random positions of anti-PVP 
antibody clones. Besides the massively dominant role of Arg, Serine (Ser) and Glutamic acid 
(Glu) also emerge as statistically over-represented in anti-Au antibody sequences, where they are 
found in the VH-CDR2 domain, albeit to a much lesser extent than Arg. 
The observed predominance of Arg residues in our anti-Au antibodies is in agreement with 
recent molecular dynamics analysis on free amino-acids 24,25  or proteins containing β-sheet 
structures 26 interacting with [111] facets of crystalline gold surfaces. In these simulations 24,25, 
arginine is ranked respectively 1st and 6th out of the 20 free amino-acids, with an interaction 
energy as high as that of the sulfur-containing amino-acids, methionine and cysteine. 
Importantly, such thiolated residues are eliminated by our method due to the oxidizing conditions 
during antibody secretion by bacteria (see Experimental Section). In the case of β-sheet 
structures, time-lapsed simulations show that arginine residues play a crucial role in the initial 
contact with gold surfaces through interactions via their side chain 26. 
Experimentally, arginine has been identified as a recurrent residue in the sequences of peptides 
that show strong affinity for gold surfaces. For example, arginine is the 3rd most represented 
amino-acid in gold-binding cyclic peptides isolated by bacterial cell-display. 11 Arginine also 
contributes to the decapeptide secreted by the bacterium D. acetovorans to precipitate Au 
nanoparticles as part of a protection mechanism against gold poisoning 27. Interestingly, arginine 
does not appear in unstructured linear peptides isolated by phage-display against bare gold 
surfaces 28,29. It is therefore possible that the interaction of arginine with gold surface may 
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critically depend on the chemical or conformational context of a well-defined folded protein or 
constrained oligopeptides, while the ubiquitous cysteine and methionine affinity for gold rely 
primarily on the sulfur-gold iono-covalent bond formation. 
 
Antibody-mediated interaction can be exploited to design complex self-assembly 
schemes in which surface affinity drives the construction of functional nanomaterials. To 
illustrate this bio-inspired self-assembly strategy, Au nanoparticles are derivatized with anti-Au 
antibodies, the gold affinity of which is subsequently used to drive the nanoparticle assembly 
predominantly onto the basal [111] facets of crystalline Au prisms (Fig. 4). First, the anti-Au 
antibodies that comprise a hexahistidine tag are coupled to 5-nm Ni-NTA-NanoGold at an 
equimolar ratio, using a standard protocol (See Experimental Section). PVP-coated Au 
nanoprisms synthesized as previously reported 30 are scattered on a clean glass substrate. 
Repeated oxygen plasma cycles are performed in order to remove the PVP capping layer while 
preserving the crystalline facets of the prisms (Figs. 4a-b). The cleaned prisms are then 
immediately incubated with a solution of antibody-conjugated Au nanoparticles followed by 
extensive rinsing with deionized water and blow dried (Fig. 4d). Atomic Force Microscopy 
(AFM) images of the resulting NanoGold-decorated Au nanoprisms show that the initially 
smooth prism surface, displayed in Figure 4b, is constellated with numerous protrusions of 
uniform height comprised between 3 and 5 nm (Fig. 4e and inset). Notably, very few 
nanoparticles are found on the silica substrate near the nanoprism, thus indicating that the 
antibody-functionalized NanoGold has a specific affinity for gold surfaces that results in an 
interaction strong enough to withstand the thorough rinsing step. Moreover, since the native 
surface of the prisms is coated with PVP, we could compare the affinity of anti-PVP and anti-Au 
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antibodies for as-synthesized PVP-coated and plasma-cleaned Au nanoprisms. Hence, our 
protocol is directly applied to Au nanoprisms deposited onto a glass substrate but without 
performing the O2 plasma step. The prisms are exposed to NanoGold functionalized with an anti-
PVP antibody through a histidine / Ni-NTA coupling (Fig. 4d). Subsequent AFM images also 
demonstrate that nanoparticles of typically 3-5 nm height are attached specifically onto the 
PVP/Au surface as shown in Figure 4f. In the case of pristine prisms, we could also perform the 
self-assembly step in aqueous suspension and then examine the Au nanoprisms by Transmission 
Electron Microscopy, which confirms the attachment of anti-PVP NanoGold nanoparticle onto 
the surface of the PVP-coated nanoprisms (See Supplementary Information). Cross-conjugation 
tests in which pristine (resp. plasma-cleaned) nanoprisms are incubated with NanoGold bearing 
anti-Au (resp. anti-PVP) antibodies yield nanoprisms with unaltered smooth surface as observed 
by AFM. This series of conjugation experiments demonstrates the principle of antibody-driven 
assembly of nanoparticles onto the larger colloids exposing surfaces of the same material used 
for their selection by phage display. The affinity and selectivity of the selected antibodies for Au 
vs PVP, PVP vs silica and Au vs silica appears to be high enough to envision the antibody-
mediated construction of functional self-assembled plasmonic architectures. 
Indeed the close packing of small metallic colloids modifies their starting plasmonic properties 
such as the emergence of long range coupled modes 31,32. The Au nanoprisms shown in Figure 4 
act as plasmonic resonators sustaining specific higher-order surface plasmon (SP) modes in the 
visible to infrared range. In particular, the experimental monitoring and the numerical 
simulations of the surface plasmon local density of states (SP-LDOS) in isolated and coupled 
nanoprisms reveal that these modes can be spectrally and spatially tuned by shape and size 
control 33 or by interparticle coupling 30. Our numeric tool mainly based on the Green dyadic 
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method (GDM) computes accurately the local electromagnetic properties, including SP-LDOS, 
of 3D metal architectures with complex geometries lying or not on a substrate 19. We have 
applied this technique to observe how the presence of additional gold nanoparticles perturb the 
initial SP-LDOS map of Au nanoprisms as shown in Figure 5 for one particular SP mode of a 
triangular nanoprism of 700 nm edge length. In the absence of nanoparticles, the spatial 
distribution of the SP mode centered at 683 nm is strongly concentrated at the center of the 
prisms with peripheral features along the edges (Figs. 5a-b). Upon random adsorption of a few 
nanoparticles on the top basal surface (Fig. 5c-d), the SP-LDOS is redistributed with a marked 
attenuation of the central feature and a concomitant reinforcement of the edge features. Figures 
5e and 5f display the SP-LDOS differences and clearly evidence the significant reshaping of the 
SP modal structure of the initial Au nanoprisms, in spite of the comparatively small diameter of 
the nanoparticles. The underlying mechanism of this self-assembly-driven SP-LDOS 
redistribution can be ascribed to spectral detuning of the mode or an alteration of its quality 
factor in the modified structure. 
 
As a conclusion, the results of our work are threefold. First, we have demonstrated that antibody 
proteins with affinity for inorganic surfaces can be selected from random libraries without any a 
priori knowledge on the interaction mechanisms between proteins and the targeted solid surface. 
We confirm that the chemical diversity of current synthetic antibody repertoires is sufficient to 
obtain strong binders of non-biological targets, the specificity of which matches the one typically 
encountered in biomolecular antibody/antigen interactions 34. Even though the intimate 
interactions between proteins and inorganic solid surfaces are far from being understood in 
general, our results provide some new insights. Our comprehensive statistical sequence analysis 
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of the selected anti-Au antibodies shows that arginine residues are strongly selected throughout 
CDR regions where they probably play a major role in the specific gold surface chemisorption. 
Second, the selected anti-Au and anti-PVP antibodies could be mass-produced and tethered to 
functionalized Au nanoparticles through their histidine tag without losing their anti-Au or anti-
PVP activity. Using both antibodies, we were able to demonstrate the protein-driven self-
assembly of gold nanoparticle-nanoprisms superstructures. Finally, we showed that such 
assembly results in a sizeable modification of the plasmonic properties of the starting Au 
nanoprisms. Our approach opens the way to colloid-based sensing design opportunities and to 
the reversible tailoring of the optical response of plasmonic information processing devices 
based on crystalline metallic nanostructures. 
  
 13 
Materials and Methods 
Phage display. The Tomlinson I+J library (22) was provided by Source Bioscience and 
screened against gold powder (purchased from SIGMA) according to the accompanying protocol 
(http://lifesciences.sourcebioscience.com/media/143421/tomlinsonij.pdf) and to our own 
protocols 35. 1012 to 1013 phages were prepared by superinfection with helper M13 KO7 phage 
(GE Healthcare) of exponentially growing TG1 E. coli in 2xTY medium, followed by overnight 
growth at 30°C, PEG (30% w/v)/NaCl (1.5 M) precipitation at 4°C and resuspension in 1 mL 
PBS. To eliminate polypropylene-binding clones from the libraries, negative selection was 
performed by incubating the amplified phages suspended in PBS + Tween20 (0.1% w/v, Sigma-
Aldrich) + Milk (2% w/v, Marvel fat free) in plain polypropylene 1.5 mL tubes for 1 h at room 
temperature. The pre-adsorbed library was then incubated on a rocker allowing the phage 
solution to be shaken evenly for 1 h at room temperature in a polypropylene 1.5 mL tube 
containing 20 mg gold powder that had been blocked prior to selection with PBS + milk (2% 
w/v) for 1 hour at room temperature (to avoid non-specific binding). Next, after a 5 s 
centrifugation on a bench-top centrifuge, the phage solution was removed from the tube, which 
was subsequently washed 10 times for 5 s with PBS + Tween20 (0.1% w/v) (first round) and 20 
times (subsequent rounds) to remove non-specific binders, each time after a 5 s centrifugation. 
Bound phages were eluted using 1 mL of 100 mM triethylamine (Sigma-Aldrich) for 20 mn and 
neutralized with 500 µL of Tris buffer (1 M, pH 7.2). Eluted phages were recovered by infection 
of an excess of exponentially growing TG1 E. coli cells (14 mL of a 2xTY culture at 
O.D.600 nm = 0.5) for titration and phage preparation for subsequent rounds of selection. 
Expression of selected recombinant antibodies. 94 selected antibody clones were picked 
randomly after the 3rd selection round and arrayed into 2 mL 96-well plates. Soluble antibody 
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production was initiated by inoculating 10 µL of an overnight saturated culture (2xTY + 
Ampicillin + 1% w/v Glucose at 37°C) into 1 mL of 2xTY + Ampicillin + 0.1% w/v Glucose at 
37°C. Induction of antibody expression (under the control of the Lac promoter in the Tomlinson 
library vector) was performed by adding 1 mM IPTG (Isopropyl β-D-1-thiogalactopyranoside, 
Sigma-Aldrich) to the culture reaching O.D.600 nm = 0.5, followed by further incubation for 18 
hours at 30°C. Soluble antibodies were secreted into the culture medium at a yield of 1 to 
10 mg/L. The culture supernatant was then directly used as primary antibody for the ELISA 
tests. For large-scale production, the expression conditions are scaled up to get a culture of 
500 mL. Antibodies are purified on cobalt-ion resin (Co-IDA, Jena Bioscience) through their 
His6 tag (the Tomlinson library vectors harbor a C-terminal His6 tag sequence downstream of 
the antibody sequence). Briefly, a 500 mL culture is centrifuged at 10,000xg for 10 minutes and 
the pellet containing bacteria and debris is discarded. The culture medium is then passed 3 times 
at 4°C (the procedure is done in a cold room from then on until the end) onto a column 
containing 1 mL of cobalt-ion resin that had been washed with 10 mL PBS. The column is then 
washed with 10 mL of PBS + 5 mM imidazole and eluted with 10 mL PBS + 250 mM imidazole 
(Sigma-Aldrich). 500 µL fractions are collected, dialyzed against PBS, and analyzed by SDS-
PAGE. Importantly, the formation of disulfide bonds by sulfhydryl groups in the oxidizing 
conditions during antibody secretion by bacteria strongly selects against the presence of cysteine 
residues in the CDR regions of the screened antibodies. Indeed, in spite of the well-known 
interactions of thiol groups with gold surfaces, we did not identify any cysteine residue at any of 
the random positions of selected anti-Au antibodies, which may have been eliminated even if 
such residues had been selected at the phage display stage. 
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ELISA binding assay. A volume of 100 µL of culture medium containing secreted antibodies 
(or only 2xTY medium for negative controls) was incubated for 1 h at room temperature in 
1.5 mL polypropylene tubes (that had been blocked with 1 mL PBS + 0.1% Tween20 + 2% 
Milk) with or without 1 mg target (Au, Ag, Cu or ZnS powders, Sigma-Aldrich). After 10 s 
centrifugation on a bench-top centrifuge, the culture medium was discarded and the tube, 
containing or not the powder target, was rinsed for 15 s in PBS + 0.1% Tween20. Next, a volume 
of 100 µL of anti-His6 antibody (HIS-1, SIGMA) diluted at 1/1000 in PBS + 0.1% Tween20 + 
2% Milk was incubated for 1 h. After rinsing again the tube with PBS + 0.1% Tween20, 100 µL 
of HRP-conjugated secondary antibodies diluted at 1/3000 in PBS + 0.1% Tween20 + 2% Milk 
was incubated for 1 h. After rinsing, the ELISA was developed using tetramethylbenzidine 
(TMB, Sigma-Aldrich). All tests were carried out in duplicate on two separate occasions, and 
were fully reproducible. Importantly, we noticed that many anti-Au antibodies bind weakly to 
polystyrene, which precluded the use of polystyrene plates or tubes during binding assay 
experiments. Previously described polystyrene-binding peptides contain arginine residues, as our 
anti-Au antibodies do, which may explain our observation. 
Sequencing and antibody sequence analysis. Phagemid DNA of anti-Au antibody clones, 
randomly picked antibody clones and anti-PVP antibody clones was purified with miniprep kits 
from Macherey-Nagel. Sequencing was done at GATC Biotech using the pHEN-SEQ primer, 
and DNA sequences were translated into amino-acid sequences using TransSeq from EMBOSS. 
We observed many amber codons (TAG) in the sequences of anti-Au antibodies, all located in 
the VH-CDR2 regions. These are suppressed and translated as glutamic acid by TG1 E. coli 
(supE genotype) used in our study for phage-display and antibody expression. Amber codons 
were accordingly translated as glutamic acid. Amino-acid sequences were aligned using the 
 16 
ClustalW 2.1 web-based algorithm (www.ebi.ac.uk/Tools/msa/). Sequence logo was performed 
using the weblogo (v. 2.8.2) web-based application (http://weblogo.berkeley.edu/logo.cgi). 
Statistical tests were performed with R software (www.r-project.org/). 
Coupling of anti-Au or anti-PVP antibodies to 5-nm gold nanoparticles. Anti-Au 
antibodies produced in this work and anti-polyvinylpyrrolidone (PVP) antibodies produced as 
described in reference 18. The as-produced antibody stock solutions are aliquoted and flash-
frozen. Just before use, the aliquots are thawed to 4°C. The antibodies are diluted from the initial 
stock solution (> 1 mg/mL) to 0.01 µM in 20 mM PBS at pH 7 with 150 mM NaCl. The 
antibody solution are then incubated with the same molar concentration (0.01 µM) of 5 nm Ni-
NTA-Nanogold (purchased from NanoProbes Inc.) for 30 minutes at 4°C. The antibody-labeled 
Nanogold particles are collected by centrifugal filtration with 50K MWCO Amicon filter spun at 
5000 rpm for 30 mins. 
Self-assembly of Nanogold onto crystalline gold nanoprisms. PVP-coated Au nanoprisms 
were produced as described elsewhere 30.A 10 µL droplet of nanoprisms suspension is drop-
casted onto a clean oxidized (100 nm SiO2) silicon wafer chip and left to dry. For anti-PVP 
antibody conjugation, the nanoprisms samples are used as such. In order to expose the crystalline 
gold surface for anti-Au antibody conjugation, substrates with PVP-coated nanoprisms are 
placed in a O2 plasma cleaner for several 3-minute cycles just before self-assembly 30. 
For both anti-PVP and anti-Au antibodies, 10-20 mL of antibody-bearing nanogold solutions 
(0.01 mM) were added on top of the exposed gold surface of gold nanoprism and incubated for 1 
hour at room temperature. The excess liquid was carefully wicked away with filter paper. The 
substrate was thoroughly rinsed several times with phosphate buffer, deionized water and finally 
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dried using nitrogen gas. The samples were analyzed by AFM (Bruker DI 3000) used in Tapping 
Mode. 
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Supporting Information. 
Supporting Information contains: (1) Anti-Au antibody sequences and (2) TEM images of PVP-
coated Au NPR with nanoGold. This material is available free of charge via the Internet at 
http://pubs.acs.org. 
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ABBREVIATIONS. AFM, Atomic Force Microscope. CDR, Complementary Determining 
Region. Co-IDA, Cobalt(II)- IminoDiacetic Acid. ELISA, Enzyme-Linked ImmunoSorbent 
Assay. GDM, Green dyadic method. HRP, horseradish peroxidase. IPTG, Isopropyl β-D-1-
thiogalactopyranoside. Ni-NTA, Nickel(II) NitriloTriacetic Acid. NMR, Nuclear Magnetic 
Resonance. PBS, Phosphate-Buffered Saline. PEG, poly-ethyleneglycol. PVP, poly-
vinylpyrrolidone. scFv, single chain variable Fragment. SDS-PAGE, sodium dodecylsulfate 
polyacrylamide gel electrophoresis. SP-LDOS, Surface Plasmon Local Density of States. TEM, 
Transmission Electron Microscopy.  
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Figure 1. Producing anti-Au antibodies by phage-display screening of antibody libraries. (a) The 
fragment V of antibodies comprises the variable regions of heavy and light chains (respectively 
VH and VL), the association of which is generally thought to shape the antigen-binding pocket. 
VH and VL each possess three complementary determining regions (CDR) corresponding to 
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hypervariable sequences (stretches of 5-10 amino-acids, typically 30% of the fragment V 
sequence overall) that determine binding specificity. Recombinant antibodies of the single-chain 
fragment V (scFv) format result from the linking of VH and VL via a flexible glycine/serine 
linker. scFvs recapitulate the binding specificity/chemistry of their natural antibody counterparts. 
(b) Fusion of a scFv-encoding DNA sequence to that of phage surface protein results in the 
display of this scFv on the phage surface, which provides a physical link between a phage-
displayed scFv antibody and its encoding DNA sequence inside the phage capsid. (c) Large, 
random antibody libraries mimicking natural immune repertoires are screened in vitro by phage-
display, i.e. alternating cycles of selection against a target antigen and amplification of selected 
antibody-encoding DNA sequences via phage infection of E. coli host bacteria (2 days per 
cycle). In the Tomlinson I+J antibody library used in the present study, most residues in the CDR 
regions of scFv antibodies are random while other residues (in the framework regions) are kept 
constant. During selection, phages that display antibody clones that do not interact strongly with 
the target are washed away while phages displaying anti-Au antibodies are selected. After 
generally 3 or 4 cycles of phage-display selection and amplification in bulk, selected antibody 
clones are arrayed in 96-well plates and tested individually for binding to the target of interest, 
here gold. 
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Figure 2. Identification of anti-Au antibodies and their binding specificity. (a) 94 antibody 
clones randomly picked from the 3rd selection round output population were tested for binding to 
gold using an ELISA binding assay. For each of the 94 antibody clones the culture medium 
containing secreted antibody was incubated in the presence of gold powder (in duplicate) or not, 
in a test tube. The intensity of the yellow color relates to the amount of antibody bound to the 
gold powder. 48% of the 94 clones tested bind to gold, and none of them binds to the test tube. 4 
antibody clones are shown here. AuA3 and AuC3 antibody clones do not bind gold; AuB3 and 
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AuD3 antibody clones bind gold. (b) Identified anti-Au antibodies were tested again negative 
control targets, Ag, Cu, and ZnS. Au was used as positive control target. None of the anti-Au 
antibodies binds to either Ag, Cu or ZnS. (c) The anti-PVP antibody clone PVPT3A2 isolated 
from the same library (sharing the same antibody scaffold) was tested for binding to gold. 2xTY 
medium was used as a negative control, and the AuD11 anti-Au antibody as a positive control 
(b). The anti-PVP T3A2 antibody did not bind to gold, ruling out non-specific interactions 
between the antibody scaffold of the Tomlinson I+J library with gold. 
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Figure 3. Statistical analysis of anti-Au antibody sequences. Sequence logo analysis was 
performed for 21 distinct anti-Au antibody clones (middle) and 31 distinct antibody clones that 
were randomly picked from the initial library (top). At each of the 18 random positions, the 
frequency of each of the 20 amino-acids is computed, and the information content derived. The 
size of letters representing amino-acids is proportional to their corresponding information 
content. The 2nd, 6th and 8th positions of VH-CDR2, the 2nd and 3rd positions of VL-CDR2 and the 
5th position of VL-CDR3 are fixed in the library and the corresponding constant amino-acids 
(respectively I, G, T, A, S, P) show scores of nearly 4 bits (i.e. the maximum score of any amino-
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acid at any random position). Arginine residues (R) are strongly enriched at most random 
positions across all 4 CDR regions in anti-Au antibodies, in comparison to randomly picked 
antibody clones from the initial library or anti-PVP antibody clones (bottom) from the same 
library 18. 
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Figure 4. Antibody-driven self-assembly of plasmonic Au nanoparticles. (a, c) AFM and (b) 
TEM images of crystalline Au nanoprisms synthesized as described in reference 30. The Au 
nanoprisms that are natively stabilized with PVP are deposited onto oxidized silicon substrate 
and used (a) with or (c) without a O2 plasma cleaning step that removed the polymer coating. In 
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(a), the inset shows the height profiles before (white) and after (black) O2 plasma cleaning that 
indicate a reduction of 3-5 nm attributed to the PVP layers. (d) Scheme of the protocol used to 
expose the bare [111] crystalline facets or the PVP-coated surface (in green) of the Au 
nanoprisms (in orange) to the selected anti-Au or anti-PVP antibody solutions. (e) AFM image of 
a Au nanoprism stripped from its PVP coating and thus specifically recognized by the anti-Au 
antibody tagged with 5-nm Au nanoparticles (yellow dots). Inset: Height profile showing a few 
3-5 nm particles on top of the nanoprisms surface. (f) AFM image of a pristine Au nanoprism 
incubated with anti-PVP antibody tagged with 5-nm Au nanoparticles. The specific attachment 
to the PVP layer is revealed by the Au nanoparticle adsorption (yellow dots). Inset: Height 
profile showing a few 3-5 nm particles on top of the nanoprisms surface. (e) and (f) share the 
same Z color scale bar. Scale bars (a, e, f) 500 nm, (b, c) 1 µm. 
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Figure 5. Plasmonic modal engineering in self-assembled Au nanoprisms / nanoparticle 
conjugates. (a) Simulation model of a Au nanoprism with edge length of 700 nm. (b) LDOS map 
calculated at 683 nm corresponding to a higher order mode (m=4) in the absence of coupled 
nanoparticles. (c) Simulation model of the Au nanoprism shown in (a) on which six 30 nm 
diameter spherical Au nanoparticles are randomly adsorbed. (d) LDOS map calculated at 683 nm 
in the presence of the six nanoparticles. (e, f) 3D and 2D maps of the LDOS difference obtained 
by subtracting map (b) from map (d). The self-assembly of nanoparticles on the nanoprisms 
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surface significantly reshape the spatial distribution of the plasmonic LDOS. Common scale bar 
is 200 nm. 
  
 30 
REFERENCES 
(1) Dujardin, E.; Mann, S. Synthesis and Assembly of Nanoparticles and Nanostructures Using 
Bio‐ Derived Templates. In Nanobiotechnology II: More Concepts and Applications; Mirkin, C. 
A.; Niemeyer, C. M., Eds.; Nanobiotechnology II: More Concepts and Applications: Weinheim, 
2007; pp. 39–58. 
(2) Park, S. Y.; Lytton-Jean, A. K. R.; Lee, B.; Weigand, S.; Schatz, G. C.; Mirkin, C. A. DNA-
Programmable Nanoparticle Crystallization. Nature 2008, 451, 553–556. 
(3) Nykypanchuk, D.; Maye, M. M.; van der Lelie, D.; Gang, O. DNA-Guided Crystallization of 
Colloidal Nanoparticles. Nature 2008, 451, 549–552. 
(4) Rowan, S. J.; Cantrill, S. J.; Cousins, G. R. L.; Sanders, J. K. M.; Stoddart, J. F. Dynamic 
Covalent Chemistry. Angew Chem Int Ed Engl 2002, 41, 898–952. 
(5) Giuseppone, N.; Fuks, G.; Lehn, J.-M. Tunable Fluorene-Based Dynamers Through 
Constitutional Dynamic Chemistry. Chemistry 2006, 12, 1723–1735. 
(6) Bradbury, A. R. M.; Sidhu, S.; Dübel, S.; Mccafferty, J. Beyond Natural Antibodies: the Power 
of in Vitro Display Technologies. Nature Biotechnology 2011, 29, 245–254. 
(7) Whaley, S. R.; English, D. S.; Hu, E. L.; Barbara, P. F.; Belcher, A. M. Selection of Peptides 
with Semiconductor Binding Specificity for Directed Nanocrystal Assembly. Nature 2000, 405, 
665–668. 
(8) Mao, C.; Solis, D. J.; Reiss, B. D.; Kottmann, S. T.; Sweeney, R. Y.; Hayhurst, A.; Georgiou, 
G.; Iverson, B.; Belcher, A. M. Virus-Based Toolkit for the Directed Synthesis of Magnetic and 
Semiconducting Nanowires. Science 2004, 303, 213–217. 
(9) Sanghvi, A. B.; Miller, K. P.-H.; Belcher, A. M.; Schmidt, C. E. Biomaterials Functionalization 
Using a Novel Peptide That Selectively Binds to a Conducting Polymer. Nature Materials 2005, 
4, 496–502. 
(10) Tamerler, C.; Oren, E. E.; Duman, M.; Venkatasubramanian, E.; Sarikaya, M. Adsorption 
Kinetics of an Engineered Gold Binding Peptide by Surface Plasmon Resonance Spectroscopy 
and a Quartz Crystal Microbalance. Langmuir 2006, 22, 7712–7718. 
(11) Hnilova, M.; Oren, E. E.; Seker, U. O. S.; Wilson, B. R.; Collino, S.; Evans, J. S.; Tamerler, C.; 
Sarikaya, M. Effect of Molecular Conformations on the Adsorption Behavior of Gold-Binding 
Peptides. Langmuir 2008, 24, 12440–12445. 
(12) So, C. R.; Tamerler, C.; Sarikaya, M. Adsorption, Diffusion, and Self-Assembly of an 
Engineered Gold-Binding Peptide on Au(111) Investigated by Atomic Force Microscopy. Angew 
Chem Int Ed Engl 2009, 48, 5174–5177. 
(13) Rothenstein, D.; Claasen, B.; Omiecienski, B.; Lammel, P.; Bill, J. Isolation of ZnO-Binding 12-
Mer Peptides and Determination of Their Binding Epitopes by NMR Spectroscopy. J Am Chem 
Soc 2012, 134, 12547–12556. 
(14) Lee, Y. J.; Yi, H.; Kim, W.-J.; Kang, K.; Yun, D. S.; Strano, M. S.; Ceder, G.; Belcher, A. M. 
Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus 
Genes. Science 2009, 324, 1051–1055. 
(15) Dang, X.; Yi, H.; Ham, M.-H.; Qi, J.; Yun, D. S.; Ladewski, R.; Strano, M. S.; Hammond, P. T.; 
Belcher, A. M. Virus-Templated Self-Assembled Single-Walled Carbon Nanotubes for Highly 
Efficient Electron Collection in Photovoltaic Devices. Nature Nanotechnology 2011, 6, 377–
384. 
(16) Artzy Schnirman, A.; Zahavi, E.; Yeger, H.; Rosenfeld, R.; Benhar, I.; Reiter, Y.; Sivan, U. 
Antibody Molecules Discriminate Between Crystalline Facets of a Gallium Arsenide 
Semiconductor. Nano Lett. 2006, 6, 1870–1874. 
(17) Watanabe, H.; Nakanishi, T.; Umetsu, M.; Kumagai, I. Human Anti-Gold Antibodies: 
Biofunctionalization of Gold Nanoparticles and Surfaces with Anti-Gold Antibodies. J Biol 
Chem 2008, 283, 36031–36038. 
(18) Soshee, A.; Zürcher, S.; Spencer, N. D.; Halperin, A.; Nizak, C. General in Vitro Method to 
 31 
Analyze the Interactions of Synthetic Polymers with Human Antibody Repertoires. 
Biomacromolecules 2014, 15, 113–121. 
(19) Girard, C.; Dujardin, E.; Baffou, G.; Quidant, R. Shaping and Manipulation of Light Fields with 
Bottom-Up Plasmonic Structures. New J. Phys. 2008, 10, 105016. 
(20) Modi, S.; Nizak, C.; Surana, S.; Halder, S.; Krishnan, Y. Two DNA Nanomachines Map pH 
Changes Along Intersecting Endocytic Pathways Inside the Same Cell. Nature Nanotechnology 
2013, 8, 459–467. 
(21) Modi, S.; Halder, S.; Nizak, C.; Krishnan, Y. Recombinant Antibody Mediated Delivery of 
Organelle-Specific DNA pH Sensors Along Endocytic Pathways. Nanoscale 2013, 6, 1144–
1152. 
(22) de Wildt, R. M.; Mundy, C. R.; Gorick, B. D.; Tomlinson, I. M. Antibody Arrays for High-
Throughput Screening of Antibody-Antigen Interactions. Nature Biotechnology 2000, 18, 989–
994. 
(23) Mason, J. M.; Müller, K. M.; Arndt, K. M. Protein Engineering Protocols; Methods in molecular 
biology (Clifton, N.J.), 2007; Vol. 352, pp. 35–70. 
(24) Feng, J.; Pandey, R. B.; Berry, R. J.; Farmer, B. L.; Naik, R. R.; Heinz, H. Adsorption 
Mechanism of Single Amino Acid and Surfactant Molecules to Au {111} Surfaces in Aqueous 
Solution: Design Rules for Metal-Binding Molecules. Soft Matter 2011, 7, 2113–2120. 
(25) Hoefling, M.; Iori, F.; Corni, S.; Gottschalk, K. E. Interaction of Amino Acids with the Au(111) 
Surface: Adsorption Free Energies From Molecular Dynamics Simulations. Langmuir 2010, 26, 
8347–8351. 
(26) Hoefling, M.; Monti, S.; Corni, S.; Gottschalk, K. E. Interaction of Β-Sheet Folds with a Gold 
Surface. PLoS ONE 2011, 6, e20925. 
(27) Johnston, C. W.; Wyatt, M. A.; Li, X.; Ibrahim, A.; Shuster, J.; Southam, G.; Magarvey, N. A. 
Gold Biomineralization by a Metallophore From a Gold-Associated Microbe. Nat Chem Biol 
2013. 
(28) Braun, R.; Sarikaya, M.; Schulten, K. Genetically Engineered Gold-Binding Polypeptides: 
Structure Prediction and Molecular Dynamics. Journal of Biomaterials Science, Polymer Edition 
2002, 13, 747–757. 
(29) Tamerler, C.; Kacar, T.; Sahin, D.; Fong, H.; Sarikaya, M. Genetically Engineered Polypeptides 
for Inorganics. Mat Sci Eng C-Bio S 2007, 27, 558–564. 
(30) Viarbitskaya, S.; Teulle, A.; Marty, R.; Sharma, J.; Girard, C.; Arbouet, A.; Dujardin, E. 
Tailoring and Imaging the Plasmonic Local Density of States in Crystalline Nanoprisms. Nature 
Materials 2013, 12, 426–432. 
(31) Lin, S.; Li, M.; Dujardin, E.; Girard, C.; Mann, S. One-Dimensional Plasmon Coupling by Facile 
Self-Assembly of Gold Nanoparticles Into Branched Chain Networks. Adv. Mater. 2005, 17, 
2553–2559. 
(32) Jägeler-Hoheisel, T.; Cordeiro, J.; Lecarme, O.; Cuche, A.; Girard, C.; Dujardin, E.; Peyrade, D.; 
Arbouet, A. Plasmonic Shaping in Gold Nanoparticle Three-Dimensional Assemblies. J. Phys. 
Chem. C 2013, 117, 23126–23132. 
(33) Viarbitskaya, S.; Teulle, A.; Cuche, A.; Sharma, J.; Girard, C.; Dujardin, E.; Arbouet, A. 
Morphology-Induced Redistribution of Surface Plasmon Modes in Two-Dimensional Crystalline 
Gold Platelets. Appl. Phys. Lett. 2013, 103, 131112. 
(34) Nizak, C.; Monier, S.; del Nery, E.; Moutel, S.; Goud, B.; Perez, F. Recombinant Antibodies to 
the Small GTPase Rab6 as Conformation Sensors. Science 2003, 300, 984–987. 
(35) Nizak, C.; Moutel, S.; Goud, B.; Perez, F. Selection and Application of Recombinant Antibodies 
as Sensors of Rab Protein Conformation. Meth Enzymol 2005, 403, 135–153. 
 
 1 
Selection of Arginine-Rich Anti-Gold Antibodies 
Engineered for Plasmonic Colloid Self-Assembly 
Purvi Jain1, Anandakumar Soshee1, S Shankara Narayanan3, Jadab Sharma3, Christian Girard3, 
Erik Dujardin3*, Clément Nizak1,2* 
1 Laboratory of Interdisciplinary Physics, UMR5588 Grenoble Université 1/CNRS, Grenoble, 
France. 
2 Laboratory of Biochemistry, UMR 8231 ESPCI ParisTech/CNRS, Paris, France. 
3 CEMES CNRS UPR 8011, 29 rue J. Marvig, 31055 Toulouse Cedex 4, France. 
 
Supplementary Information 
Table S1: Sequence alignment table for anti-Au antibodies. 
Figure S2: TEM of Anti-PVP derivatized Nanogold attached to the surface of Au nanoprisms 
  
 2 
Table S1: Sequence alignment table for anti-Au antibodies. 
PC1_D1_E2_D7_C8_H9_C10_C6      SIPEEGSSTT--NSGL--AASY--ASRRPT 
PD4                            SIAELGARTR--NLSV--SASY--GSTAPT 
PA2                            SIEREGPKTR--NSAL--SASR--AAAKPT 
PC2_B12                        SIESYGSRTN--GRVL--SASH--ARHPPT 
PG8                            SITTVGEPTR--NGTP--AASR--ARHPPI 
PG2                            EINNSGDRTR--RGRR--QASR--RRAKPR 
PF5                            GIEARGGKTA--KRRH--AASR--RTAYPR 
PB2                            SISERGKPTR--PGRK--DASL--IPLLPP 
PA7                            SISETGKITM--AGRK--RASH--RRQRPR 
PD5                            SISPRGMETK--LNRR--RASR--HGKRPR 
PE6                            SISSRGRETR--FRSR--MASH--RKTGPR 
PH4                            AITREGYGTW--KGRR--KASR--ARKQPS 
PB7                            AITREGYGTW--KGRR--RASR--RYLKPG 
PC4                            SIGVEGLHTS--RSAT--KASN--SRKTPP 
PD11                           SIGQHGGVTM--RRAT--HAST--SRKSPP 
PD2                            NIEREGTATS--RTAT--RASH--SAHRPP 
PB3_A9                         GITPLGRLTE--RLAT--KASL--AANRPP 
PG7                            GIAQEGRHTE--RSAT--KASR--GAEAPV 
PA4                            TISREGHGTS--RAAR--TASR--AAARPE 
PA5_H11                        TISREGHGTS--RAAR--TASR--AAARPA 
PC11                           TISREGHGTS--RAAR--AASH--AVQSPQ 
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Figure S2: TEM of Anti-PVP derivatized Nanogold attached to the surface of Au nanoprisms 
 
Figure S2. Close-up Transmission Electron Micrographs (TEM) of PVP-coated gold nanoprisms 
decorated with NanoGold nanoparticles labelled with anti-PVP antibody. Scale bars (a) 50 nm, 
(b) 100nm, (c-d) 20 nm. 
 
The conjugation of Nanogold-labelled anti-PVP antibodies with PVP-coated Au nanoprisms was 
performed by coupling the anti-PVP antibody to the Ni-NTA Nanogold colloids using the 
Histidine tag as described in the Experimental Section of the main article. After centrifugal 
filtration, the Nanogold-labelled antibody was mixed with 20 µL of ultrasonicated nanoprisms 
suspension and left to incubate. Low speed centrifugation (typically 5000 rpm for 5 minutes) was 
used to retrieve the nanoprisms that were redispersed in deionized water. The nanoprisms were 
drop-casted onto Carbon-coated Formwar TEM grids for microscopy analysis. Figure S2 shows 
a series of micrographs in which the 3-5 nm NanoGold colloids adsorbed on the nanoprisms 
faces or edges can be observed, therefore confirming that the antibody-PVP interaction did drive 
the attachment of NanoGold onto the PVP-coated nanoprisms in solution. 
